FIELD: biotechnology and medical biology.
SUBSTANCE: invention relates to treatment preparation based on lactic bacteria of strain Lactobacillus acidophilus. Preparation contains 1.0-99.0 mass % of biomass of living bacteria Lactobacillus acidophilus N.V. Ep 317/402-X and balance: biomass of bacteria Lactobacillus acidophilus N.V. Ep 317/402-X, exposed to multiple freezing and thawing or autolysis, as source of cell detritus, extracellular and intracellular metabolites. Additionally preparation comprises 0.5-30.0 mg/ml of lysozyme and/or 0.001-0.1 mg/ml of nisin.
EFFECT: preparation with wide range of antagonistic activity, particularly in relation to pathogenic bacteria Helicobacter pylori associated with various forms of gastritis and duodenal and stomach ulcer, and high content of valuable substances.
2 cl, 2 tbl, 9 ex
